×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TENX – tenax therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TENX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/31
08:00 am
tenx
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Low
Report
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
3/29
02:07 am
tenx
Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/25
04:05 pm
tenx
Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Low
Report
Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
3/21
02:03 am
tenx
Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/13
02:08 am
tenx
Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/10
12:14 pm
tenx
Tenax Therapeutics, Inc. (NASDAQ: TENX) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Tenax Therapeutics, Inc. (NASDAQ: TENX) had its "outperform" rating re-affirmed by analysts at William Blair.
3/10
12:03 pm
tenx
Tenax Therapeutics, Inc. (NASDAQ: TENX) was given a new $20.00 price target on by analysts at Leerink Partners.
Low
Report
Tenax Therapeutics, Inc. (NASDAQ: TENX) was given a new $20.00 price target on by analysts at Leerink Partners.
3/5
09:56 am
tenx
Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF [Yahoo! Finance]
Medium
Report
Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
3/25
04:16 pm
tenx
Form 10-K TENAX THERAPEUTICS, INC. For: Dec 31
Low
Report
Form 10-K TENAX THERAPEUTICS, INC. For: Dec 31
3/25
04:10 pm
tenx
Form 8-K TENAX THERAPEUTICS, INC. For: Mar 25
Low
Report
Form 8-K TENAX THERAPEUTICS, INC. For: Mar 25
3/18
04:13 pm
tenx
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: S.H.N. Financial Investments Ltd.
Medium
Report
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: S.H.N. Financial Investments Ltd.
3/12
05:26 pm
tenx
Form 4 TENAX THERAPEUTICS, INC. For: Mar 05 Filed by: Dellora Investments LP
Low
Report
Form 4 TENAX THERAPEUTICS, INC. For: Mar 05 Filed by: Dellora Investments LP
3/6
05:00 pm
tenx
Form 8-K TENAX THERAPEUTICS, INC. For: Mar 04
Medium
Report
Form 8-K TENAX THERAPEUTICS, INC. For: Mar 04
2/14
12:37 pm
tenx
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: JANUS HENDERSON GROUP PLC
1/15
04:14 pm
tenx
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Dellora Investments LP
Medium
Report
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Dellora Investments LP
1/10
04:27 pm
tenx
Form 3 TENAX THERAPEUTICS, INC. For: Jan 08 Filed by: Dellora Investments LP
Medium
Report
Form 3 TENAX THERAPEUTICS, INC. For: Jan 08 Filed by: Dellora Investments LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/31
Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial
7.4%
1/15 Tenax Therapeutics Inc (NASDAQ: TENX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 4.8%
6/14 Form 8-K TENAX THERAPEUTICS, INC. For: Jun 13 4.7%
1/22 Tenax Therapeutics Inc (NASDAQ: TENX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.3%
8/23 Tenax Therapeutics Provides Clinical Development Update 3.4%
8/30 Form S-8 TENAX THERAPEUTICS, INC. 2.5%
11/8 Form 8-K/A TENAX THERAPEUTICS, INC. For: Jun 13 2.5%
4/29 Form 8-K TENAX THERAPEUTICS, INC. For: Apr 24 2.3%
3/30 Form 10-K TENAX THERAPEUTICS, INC. For: Dec 31 2.1%
2/14 Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: Iroquois Capital Management, LLC 0.0%
1/15 Tenax Therapeutics Inc (NASDAQ: TENX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 4.8%
6/14 Form 8-K TENAX THERAPEUTICS, INC. For: Jun 13 4.7%
1/22 Tenax Therapeutics Inc (NASDAQ: TENX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.3%
8/23 Tenax Therapeutics Provides Clinical Development Update 3.4%
8/30 Form S-8 TENAX THERAPEUTICS, INC. 2.5%
11/8 Form 8-K/A TENAX THERAPEUTICS, INC. For: Jun 13 2.5%
4/29 Form 8-K TENAX THERAPEUTICS, INC. For: Apr 24 2.3%
3/30 Form 10-K TENAX THERAPEUTICS, INC. For: Dec 31 2.1%
2/14 Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: Iroquois Capital Management, LLC 0.0%
TOP News Decliners
3/13
Form 8-K TENAX THERAPEUTICS, INC. For: Mar 11
-35.8%
2/29 Tenax Therapeutics Inc (NASDAQ: TENX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.8%
1/13 Form 8-K TENAX THERAPEUTICS, INC. For: Jan 13 -7.9%
4/9 Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 “HELP Study” of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction -6.7%
2/21 Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board -5.8%
2/7 Form SC 13G TENAX THERAPEUTICS, INC. Filed by: BlackRock Inc. -5.7%
3/27 Form D TENAX THERAPEUTICS, INC. -5.6%
5/15 Q1/2019 3/31/2019 EPS -0.330 ZacksConsensus N/A ActVsEst N/A - N/A -4.2%
8/14 Q2/2019 6/30/2019 EPS -0.280 ZacksConsensus -0.450 ActVsEst 0.170 - Beat -4.2%
3/23 Form SC 13G TENAX THERAPEUTICS, INC. Filed by: ARMISTICE CAPITAL, LLC -2.0%
2/29 Tenax Therapeutics Inc (NASDAQ: TENX) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -10.8%
1/13 Form 8-K TENAX THERAPEUTICS, INC. For: Jan 13 -7.9%
4/9 Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 “HELP Study” of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction -6.7%
2/21 Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board -5.8%
2/7 Form SC 13G TENAX THERAPEUTICS, INC. Filed by: BlackRock Inc. -5.7%
3/27 Form D TENAX THERAPEUTICS, INC. -5.6%
5/15 Q1/2019 3/31/2019 EPS -0.330 ZacksConsensus N/A ActVsEst N/A - N/A -4.2%
8/14 Q2/2019 6/30/2019 EPS -0.280 ZacksConsensus -0.450 ActVsEst 0.170 - Beat -4.2%
3/23 Form SC 13G TENAX THERAPEUTICS, INC. Filed by: ARMISTICE CAPITAL, LLC -2.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: